EXACTLY TEN years ago, the Supreme Court of India delivered a landmark judgement on a crucial case involving under the patent protection for pharmaceuticals country's new intellectual property rights regime. It was a case that had riveted the world since the outcome had major implications for the pharma industry and for patients. It was the first test of the country's patent law, which had been amended to comply with World Trade Organization (WTO) rules, and specifically of a particular part of the law, Section 3d, which delineated what was not patentable in India. This section deals with patents for derivatives of known substances and new uses of a known substance, a hugely contested domain.
The legal challenge had come from Swiss drug giant Novartis which had filed a special leave petition (SLP) in the apex court; its final attempt to get a patent for a new form of its anti-cancer medicine Glivec after several courts had rejected the claim. The claim was for a beta crystalline version of its base compound imatinib mesylate, which had been patented much earlier. A division bench of the Supreme Court rejected the SLP and Justice Aftab Alam, who wrote the carefully nuanced judgement, laid down the fundamental reasoning for the law and its application. While the court considered the counter arguments-generic companies, patient groups and lobbyists had also filed SLPS-it was not unduly swayed by the argument for access to the medicine.
This story is from the April 01, 2023 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 01, 2023 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 8,500+ magazines and newspapers.
Already a subscriber? Sign In
THE ALCHEMY OF EMOTIONS - SL'OTH
As with all personality traits, laziness is a combination of genes and environment
THE AL'CHEMY OF EMOTIONS - WRATH
Anger is an emotional programme, a part of natural selection that helps us bargain for better treatment
THE AL'CHEMY OF EMOTIONS - GLUTTONY
We have been captured by food and it is driving us to do something that is arguably not good for us
THE AL'CHEMY OF EMOTIONS - ENVY
Envy gives people a fundamental desire for a higher social rank
THE AL'CHEMY OF EMOTIONS-L'UST
Love, lust, attachments are basic brain circuits. They are too primitive a system and will never change
THE AL'CHEMY OF EMOTIONS - GREED
Evolutionary biology sees greed as a way to increase your chances of survival
THE AL'CHEMY OF EMOTIONS
I felt for the tormented whirlwinds Damned for their carnal sins Committed when they let their passions rule their reason
INVISIBLE THREAT
Significant presence of microplastics in Puducherry’s agricultural soil raises concerns for soil and crop health
Feeding off each other
VEGETARIAN MOVEMENTS IN SOUTH ASIA AND THE WEST GREW WITH MUTUAL SUPPORT AND VALIDATION
India's unhealthy patent amendments
Despite strong pleas, the Modi regime has changed the rules to impose a cost on those who challenge faulty patents